Home > Financial Ratios > DR LAL PATHLABS

DR LAL PATHLABS
Core EBITDA Growth

    Back to All Ratios
DR LAL PATHLABS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
AD     Remove this Ad

DR LAL PATHLABS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 16.3127.63-13.3225.7722.32

What is the latest Core EBITDA Growth ratio of DR LAL PATHLABS ?

The latest Core EBITDA Growth ratio of DR LAL PATHLABS is 16.31 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202516.31
Mar202427.63
Mar2023-13.32
Mar202225.77
Mar202122.32

How is Core EBITDA Growth of DR LAL PATHLABS Trending?

Years Core EBITDA Growth % Change
Mar2025 16.31
-40.97
Mar2024 27.63
Positive
Mar2023 -13.32
Negative
Mar2022 25.77
15.46
Mar2021 22.32 -

Other Financial Ratios of DR LAL PATHLABS


Compare Core EBITDA Growth ratio of peers of DR LAL PATHLABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
DR LAL PATHLABS ₹23,444.7 Cr 0.2% -0.7% 8.3% Stock Analytics
APOLLO HOSPITALS ENTERPRISE ₹112,443.0 Cr 1.7% 12.4% 23.1% Stock Analytics
MAX HEALTHCARE INSTITUTE ₹106,237.0 Cr 0.8% 14.1% 9.9% Stock Analytics
FORTIS HEALTHCARE ₹71,124.6 Cr 2.5% 10.6% 55.8% Stock Analytics
NARAYANA HRUDAYALAYA ₹37,468.5 Cr -1.9% 3.7% 32.2% Stock Analytics
GLOBAL HEALTH ₹30,667.6 Cr -2.1% 8.1% -5.9% Stock Analytics


DR LAL PATHLABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
DR LAL PATHLABS

0.2%

-0.7%

8.3%

SENSEX

-1.8%

-1.6%

7.3%


You may also like the below Video Courses